ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
19.00
+0.17 (0.90%)
Dec 20, 2024, 4:00 PM EST

ZIVO Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
67224276258
Upgrade
Market Cap Growth
322.41%-89.71%-12.89%-56.08%6.15%163.91%
Upgrade
Enterprise Value
68221166765
Upgrade
Last Close Price
19.001.2015.0017.2272.0079.20
Upgrade
PS Ratio
726.1787.64--3077.41-
Upgrade
PB Ratio
-27.55-1.10-2217.024.47-5.44-6.95
Upgrade
P/TBV Ratio
---4.47--
Upgrade
EV/Sales Ratio
733.4688.27--3345.19-
Upgrade
Debt / Equity Ratio
-0.18-0.16-41.910.04-0.47-0.63
Upgrade
Asset Turnover
0.060.02--0.07-
Upgrade
Quick Ratio
0.070.100.893.020.010.04
Upgrade
Current Ratio
0.170.150.943.040.010.04
Upgrade
Return on Equity (ROE)
---289.98%---
Upgrade
Return on Assets (ROA)
-657.43%-338.92%-98.22%-117.33%-1813.96%-1336.98%
Upgrade
Return on Capital (ROIC)
---162.14%-3158.25%--
Upgrade
Earnings Yield
-26.08%-320.95%-37.14%-32.39%-14.79%-19.85%
Upgrade
FCF Yield
-7.19%-239.35%-30.16%-25.17%-4.21%-6.39%
Upgrade
Buyback Yield / Dilution
-72.62%-7.65%-23.47%-50.26%-46.96%-76.41%
Upgrade
Total Shareholder Return
-72.62%-7.65%-23.47%-50.26%-46.96%-76.41%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.